Why America’s Approach to HIV Prevention Has Stalled

In the midst of news surrounding the Trump administration’s plan to eradicate HIV/AIDS in the United States by 2030, the Centers for Disease Control and Prevention (CDC) announced that the annual decline in new HIV transmission rates has leveled off.

What does this mean for plans to combat the HIV/AIDS epidemic?

Experts say that the spotlight directed by the government coupled with gains made in prevention resources over the past decade signify a clear path forward to progress.

That being said, they stress significantly more needs to be done to make an HIV/AIDS-free future anything close to being a reality. Essentially, the current approach hasn’t worked.

“Right now, we have the tools to end the epidemic,” Dr. Ronald G. Collman, director of the Penn Center for AIDS Research in Philadelphia, Pennsylvania, told Healthline. “But we have to keep addressing how people have access to prevention and care, and the structures in our healthcare systems and communities both facilitate and make it difficult for people to get care, treatment and prevention – that is really how we need to focus our efforts.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below